ID: ALA2315309

Max Phase: Preclinical

Molecular Formula: C11H12BrNS3

Molecular Weight: 334.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(C)SSc1nc2cc(Br)ccc2s1

Standard InChI:  InChI=1S/C11H12BrNS3/c1-3-7(2)15-16-11-13-9-6-8(12)4-5-10(9)14-11/h4-7H,3H2,1-2H3

Standard InChI Key:  XMHKMGRUQFLFRJ-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 334.33Molecular Weight (Monoisotopic): 332.9315AlogP: 5.60#Rotatable Bonds: 4
Polar Surface Area: 12.89Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.39CX LogP: 5.80CX LogD: 5.80
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.68Np Likeness Score: -1.23

References

1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

Source